NCT03897738View on ClinicalTrials.gov

Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B in Perimenopausal Women.

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

February 18, 2020

Study Completion Date

February 18, 2020

Conditions
Perimenopause, Climacteric Syndrome
Interventions
DIETARY_SUPPLEMENT

Amberen

Amberen is a succinate-based dietary supplement previously shown to help provide relief for common menopausal symptoms.

DIETARY_SUPPLEMENT

Smart B

Smart B contains vitamins B1, B2, B6, B9, B12 and sodium fumarate.

DIETARY_SUPPLEMENT

Placebo

Placebo capsules are identical to Amberen and Smart B capsules.

Trial Locations (1)

119991

Sechenov First Moscow Medical University, Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT03897738 - Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B in Perimenopausal Women. | Biotech Hunter | Biotech Hunter